Moreover, we report a novel paradoxical role of XAF1 in GBM adaptive resistance whereby, XAF1 expression through differential epigenetic regulation promotes both genetic and phenotypic resistance in MGMT-hyper GBM cell lines during TMZ treatment. Here, MGMT is linked to glioblastoma.